These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23896958)

  • 61. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
    Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
    J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of counseling spouse caregivers of people with Alzheimer disease taking donepezil and of country of residence on rates of admission to nursing homes and mortality.
    Brodaty H; Mittelman M; Gibson L; Seeher K; Burns A
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):734-43. PubMed ID: 19705519
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.
    Vigen CL; Mack WJ; Keefe RS; Sano M; Sultzer DL; Stroup TS; Dagerman KS; Hsiao JK; Lebowitz BD; Lyketsos CG; Tariot PN; Zheng L; Schneider LS
    Am J Psychiatry; 2011 Aug; 168(8):831-9. PubMed ID: 21572163
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
    Ballard C; Isaacson S; Mills R; Williams H; Corbett A; Coate B; Pahwa R; Rascol O; Burn DJ
    J Am Med Dir Assoc; 2015 Oct; 16(10):898.e1-7. PubMed ID: 26239690
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
    Wang PS; Schneeweiss S; Avorn J; Fischer MA; Mogun H; Solomon DH; Brookhart MA
    N Engl J Med; 2005 Dec; 353(22):2335-41. PubMed ID: 16319382
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD).
    Oh ES; Rosenberg PB; Rattinger GB; Stuart EA; Lyketsos CG; Leoutsakos JS
    J Am Geriatr Soc; 2021 Apr; 69(4):955-963. PubMed ID: 33382921
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Why and how antipsychotic drugs are used in 40 Sydney nursing homes.
    Snowdon J; Day S; Baker W
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1146-52. PubMed ID: 16315158
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment.
    Liperoti R; Sganga F; Landi F; Topinkova E; Denkinger MD; van der Roest HG; Foebel AD; Finne-Soveri H; Bernabei R; Onder G
    J Clin Psychiatry; 2017 Jan; 78(1):e76-e82. PubMed ID: 28129493
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K
    J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.
    Chui HC; Lyness SA; Sobel E; Schneider LS
    Arch Neurol; 1994 Jul; 51(7):676-81. PubMed ID: 8018040
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nursing home research from investigators' perspective.
    Finkel SI; Lyons J
    Int Psychogeriatr; 1996; 8 Suppl 3():371-3; discussion 381-2. PubMed ID: 9154591
    [No Abstract]   [Full Text] [Related]  

  • 73. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
    Reus VI; Fochtmann LJ; Eyler AE; Hilty DM; Horvitz-Lennon M; Jibson MD; Lopez OL; Mahoney J; Pasic J; Tan ZS; Wills CD; Rhoads R; Yager J
    Am J Psychiatry; 2016 May; 173(5):543-6. PubMed ID: 27133416
    [No Abstract]   [Full Text] [Related]  

  • 74. Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study.
    Herrmann N; Cappell J; Eryavec GM; Lanctôt KL
    CNS Drugs; 2011 May; 25(5):425-33. PubMed ID: 21476613
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.
    Street JS; Clark WS; Kadam DL; Mitan SJ; Juliar BE; Feldman PD; Breier A
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S62-70. PubMed ID: 11748789
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
    Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dementia and neuropsychiatric symptoms in nursing-home patients in Nord-Trøndelag County.
    Bergh S; Holmen J; Saltvedt I; Tambs K; Selbæk G
    Tidsskr Nor Laegeforen; 2012 Sep; 132(17):1956-9. PubMed ID: 23007358
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study.
    De Deyn P; Jeste DV; Swanink R; Kostic D; Breder C; Carson WH; Iwamoto T
    J Clin Psychopharmacol; 2005 Oct; 25(5):463-7. PubMed ID: 16160622
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.